Clinical Trial Update: THERApy De-escalation for TESTicular Cancer

View source ↗

Summary

Queen Mary University of London is conducting a trial evaluating therapy de-escalation for seminoma (testicular cancer); recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seminoma
• Testicular Cancer

Snippet

Sponsor: Queen Mary University of London | Conditions: Seminoma | Status: RECRUITING